MedTrace Logo

Chest CT Biomarkers as Prognostic Predictors in SSc-ILD

NCT06472362 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-09-11

No results posted yet for this study

Summary

The goal of this retrospective observational study is to investigate whether novel imaging biomarkers of airways, vessels, and overall extent of fibrosis at baseline predict ILD progression, vasculopathy development, and survival in SSc-ILD.

Conditions

Interventions

DIAGNOSTIC_TEST

HRCT biomarkers

HRCT imaging biomarkers of airways, vessels, and overall extent of fibrosis

Sponsors & Collaborators

  • Imperial College London

    collaborator OTHER

  • Royal Free and University College Medical School

    collaborator OTHER

  • The Leeds Teaching Hospitals NHS Trust

    collaborator OTHER

  • Hannover Medical School

    collaborator OTHER

  • University of Siena

    collaborator OTHER

  • Università Politecnica delle Marche

    collaborator OTHER

  • Azienda Ospedaliero Universitaria di Sassari

    collaborator OTHER

  • Bichat Hospital

    collaborator OTHER

  • Royal Brompton & Harefield NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Elisabetta A Renzoni · Royal Brompton and Harefield Hospitals

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2025-12-31
Completion
2026-03-31

Countries

  • France
  • Germany
  • Italy
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06472362 on ClinicalTrials.gov